Recruiting NA INTERVENTIONAL 1-arm NCT05829291

Alpha Radiation Emitters Device for the Treatment of Liver Metastases (DaRT)

A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Liver Metastases

Sponsor: Alpha Tau Medical LTD.

Interventions Diffusing Alpha Radiation Emitters Therapy (DaRT)

Updated 7 times since 2023 Last updated: May 9, 2024 Started: Oct 1, 2023 Primary completion: Feb 28, 2025 Completion: Feb 28, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Liver Metastases and is currently actively recruiting participants. Alpha Tau Medical LTD. leads this study, which shows 7 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Recruiting NA
Sep 2024 — Sep 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Jun 2024 — Jul 2024 [monthly]

Recruiting NA
Dec 2023 — Jun 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 2 earlier versions

Aug 2023 — Dec 2023 [monthly]

Not Yet Recruiting NA
May 2023 — Aug 2023 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Alpha Tau Medical LTD.

Data source: Alpha Tau Medical LTD.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montreal, Canada